Form 8-K - Current report:
SEC Accession No. 0001477932-23-003726
Filing Date
2023-05-18
Accepted
2023-05-18 16:30:29
Documents
15
Period of Report
2023-05-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K flora_8k.htm   iXBRL 8-K 28560
2 AMENDMENT NO. 1 TO SEPARATION AGREEMENT flora_ex101.htm EX-10.1 16173
  Complete submission text file 0001477932-23-003726.txt   170562

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA flora-20230514.xsd EX-101.SCH 5728
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flora-20230514_lab.xml EX-101.LAB 14024
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flora-20230514_cal.xml EX-101.CAL 901
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flora-20230514_pre.xml EX-101.PRE 8865
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flora-20230514_def.xml EX-101.DEF 2102
9 EXTRACTED XBRL INSTANCE DOCUMENT flora_8k_htm.xml XML 3449
Mailing Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312
Business Address 3406 SW 26TH TERRACE, SUITE C-1 FORT LAUDERDALE FL 33312 416-861-2267
Flora Growth Corp. (Filer) CIK: 0001790169 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40397 | Film No.: 23936515
SIC: 2834 Pharmaceutical Preparations